About the journal

Molecular medicine (Molekulyarnaya Meditsina)

The scientific-applied journal // ISSN -1728-2918 // eISSN 2499-9490

The journal «Molecular medicine » highlights research results in such areas as the investigation of the molecular and genetic bases of the etiology and pathogenesis of socially significant diseases with the aim to develop new diagnostic methods and Benches-to-bedside to the effective therapy of human diseases, including technology-based nuclear medicine.

Particular attention is given to the formation of principles of personalized medicine based on a fundamentally new approach both to the disease and the patient, in the context of an active introduction into the practice achievements of genomics, proteomics, metabolomics and bioinformatics, using modern knowledge and computer technologies, relying upon a wealth of international experience in this area.

The main efforts are focused as well on the creation of complex genetic cellular bioengineering medical technologies and highly effective drugs of new generation, including directional medicinal agents, drugs based on nanotechnology.

According to the Decision of the Presidium of the Higher Attestation Commission (HAC) the journal "Molecular Medicine" is included into the list of leading peer-reviewed scientific journals, in which the main results of the thesis for the degree of doctor and candidate of sciences should be published. Journal "Molecular Medicine" is included in the Russian Science Citation Index.

In 2017, the impact factor of RSCI (Russian Index of Scientific Citation) of the journal "Molecular medicine" was 0.500 (аccording to the data of the Scientific Electronic Library eLIBRARY.RU).

General information
• ISSN 1728-2918
• Frequency: 6 issues per year
• Format – А4
• Volume (pages) – 64
• Distribution - subscription, libraries, VIP-delivery, medical arrangements
• Editor-in-Chief – Academician of RAS, М.А. Paltsev